Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 8-K Event Results of operations
  2. ARS Other Annual Report to Security Holders
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. SC 13G Stake Amended Statement of Ownership
  6. 4 Insider Changes in Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Bylaws or fiscal year change
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Regulation FD disclosure
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Executive or director change
  20. EFFECT Other Notice of Effectiveness

Page 12 of 19 · 361 filings